Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

Acinetobacter baumannii is a Gram-negative, glucose-non-fermenting, oxidase-negative
coccobacillus, most commonly associated with the hospital settings. The ability to survive in …

The relationship between the multidrug-resistant (MDR) phenotype and biofilm-forming
capacity has been a topic of extensive interest among biomedical scientists, as these two …

In this study, we determined the antibacterial and synergistic activities of the essential oil
from Zingiber cassumunar against the extensively drug-resistant (XDR) Acinetobacter …

Acinetobacter baumannii is an opportunistic pathogen primarily associated with multidrug-
resistant nosocomial infections, for which polymyxins are the last-resort antibiotics. This …

Background. The spread of carbapenem‐resistant A. baumannii (CrAb) is gaining worldwide
attention. The spread of this pathogen is largely due to its ability to acquire various …

Bioaerosol is a new type of pollutant, which is related to the spread of many diseases. In
particular, the bioaerosol produced in the hospital sewage treatment process contains many …

Infections due to carbapenem-resistant NDM-producing Escherichia coli represent a major
therapeutic challenge, especially in situations of pre-existing colistin resistance. The aim of …

This study investigated the molecular epidemiology of carbapenem-resistant Acinetobacter
nosocomialis and Acinetobacter pittii (ANAP). Clinical isolates of Acinetobacter spp …